Welcome to our dedicated page for Fmc SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
FMC Corporation director C. Scott Greer reported a small equity award. On January 15, 2026, he acquired 167 shares of FMC common stock at a price of $0 per share, bringing his directly held beneficial ownership to 74,465 shares. According to the disclosure, these 167 shares were issued under dividend equivalent rights that accrued on previously granted restricted stock units once those units vested. This reflects an automatic, compensation-related share issuance rather than an open-market purchase or sale.
FMC Corporation director K'Lynne Johnson reported a small increase in her direct share ownership through a Form 4 filing. On 01/15/2026, she acquired 146 shares of FMC common stock at a price of $0 per share. The filing explains that these shares were issued as dividend equivalent rights connected to previously vested restricted stock units held by Johnson, meaning she received additional shares in lieu of cash dividends on those units. Following this transaction, she beneficially owns 35,069 FMC common shares directly. This was a routine equity-based compensation-related issuance rather than an open-market purchase or sale.
FMC Corporation director Dirk A. Kempthorne reported receiving 250 shares of FMC common stock on January 15, 2026. The shares were issued at $0 per share as dividend equivalent rights tied to vested restricted stock units held by the reporting person. After this transaction, Kempthorne directly beneficially owns 56,710 shares of FMC common stock.
FMC Corporation director Steven T. Merkt reported a small increase in his ownership of FMC common stock. On 01/15/2026, he acquired 15 shares of common stock at a price of $0 per share, bringing his directly held stake to 5,866 shares.
The filing explains that these shares were issued under dividend equivalent rights tied to vested restricted stock units already held by Merkt. This means he received additional shares to mirror dividends that would have been paid on those underlying restricted stock units, rather than through an open‑market purchase or sale.
FMC Corporation director Margareth Oevrum reported the acquisition of 103 shares of common stock on January 15, 2026. The shares were issued at $0 per share pursuant to dividend equivalent rights connected to vested restricted stock units held by her. Following this issuance, she directly owns 22,409 FMC common shares.
FMC Corporation director Robert C. Pallash received additional equity compensation in the form of common stock. On January 15, 2026, he acquired 306 shares of FMC common stock at a price of $0.00 per share through dividend equivalent rights connected to vested restricted stock units held by him. After this transaction, he directly beneficially owned 60,422 FMC common shares. This was a Form 4 filing by a single reporting person in his capacity as a director, reflecting a routine equity-based compensation accrual rather than an open‑market trade.
FMC director John Mitchell Raines reported a small equity award in the form of company stock. On January 15, 2026, he acquired 20 shares of FMC common stock at a price of $0 per share, bringing his total directly held FMC shares to 13,804 after the transaction. The shares were issued pursuant to dividend equivalent rights tied to previously vested restricted stock units, meaning he received additional shares in lieu of cash dividends on those vested awards.
FMC Corporation director Patricia Verduin reported a small stock acquisition through dividend equivalents. On 01/15/2026, she acquired 22 shares of FMC common stock in a transaction coded "A" at a price of $0 per share. According to the footnote, these shares were issued pursuant to dividend equivalent rights tied to vested restricted stock units she already held, meaning they represent dividends paid in stock rather than a market purchase. After this transaction, she beneficially owns 7,133 FMC common shares, held directly.
FMC Corporation reported a small insider share acquisition by its Chairman, CEO and President, Pierre R. Brondeau. On 01/15/2026, he acquired 36 shares of FMC common stock at a price of $0.00 per share. According to the footnote, these shares were issued as dividend equivalent rights tied to vested restricted stock units he already held, rather than a market purchase.
Following this issuance, Brondeau directly beneficially owned 300,906 shares of FMC common stock. The transaction was reported on a Form 4 filed for a single reporting person and reflects routine equity-based compensation rather than an open-market trade.
FMC Corporation reported an insider equity transaction involving a director. On 12/31/2025, the director had a transaction in Common Stock coded "F" for 73 shares disposed of at a price of $13.98 per share. Following this transaction, the director beneficially owned 31,546 shares of FMC Corporation common stock, held as direct ownership.